Company page

Annexon, Inc.

Annexon, Inc. is a public company traded under the ticker ANNX in the American market, with a market capitalization of approximately $802.8 million. The company focuses on developing innovative therapies for neurodegenerative diseases. Its commitment to advancing treatments positions it as a key player in the biotechnology sector.